{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T21:21:12Z","timestamp":1771708872740,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No.82271124"],"award-info":[{"award-number":["No.82271124"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 82301204"],"award-info":[{"award-number":["No. 82301204"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Beijing Bethune Charitable Foundation","award":["No. BJ2022IIT007"],"award-info":[{"award-number":["No. BJ2022IIT007"]}]},{"name":"Beijing Hospitals Authority Innovation Studio of Young Staff Funding Support","award":["202103"],"award-info":[{"award-number":["202103"]}]},{"name":"Training Fund for Open Projects at Clinical Institutes and Departments of Capital Medical University","award":["CCMU2022ZKYXZ001"],"award-info":[{"award-number":["CCMU2022ZKYXZ001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"DOI":"10.1186\/s12886-025-03993-1","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T07:16:20Z","timestamp":1744010180000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Predictive impact of serous retinal detachment in refractory diabetic macular edema"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1521-9913","authenticated-orcid":false,"given":"Zhuo-hua","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7191-6660","authenticated-orcid":false,"given":"Yan-ling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7877-1620","authenticated-orcid":false,"given":"Jia-lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"key":"3993_CR1","doi-asserted-by":"publisher","unstructured":"Im JHB, Jin YP, Chow R, Yan P. Prevalence of diabetic macular edema based on optical coherence tomography in people with diabetes: A systematic review and meta-analysis. Surv Ophthalmol. 2022;67(4):1244\u201351. https:\/\/doi.org\/10.1016\/j.survophthal.2022.01.009","DOI":"10.1016\/j.survophthal.2022.01.009"},{"issue":"1","key":"3993_CR2","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1001\/jamaophthalmol.2015.4110","volume":"134","author":"JS Heier","year":"2016","unstructured":"Heier JS, Bressler NM, Avery RL, Bakri SJ, Boyer DS, Brown DM, et al. Comparison of Aflibercept, bevacizumab, and Ranibizumab for treatment of diabetic macular edema: extrapolation of data to clinical practice. JAMA Ophthalmol. 2016;134(1):95\u20139. https:\/\/doi.org\/10.1001\/jamaophthalmol.2015.4110","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"3993_CR3","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1001\/jamaophthalmol.2017.6565","volume":"136","author":"NM Bressler","year":"2018","unstructured":"Bressler NM, Beaulieu WT, Glassman AR, Blinder KJ, Bressler SB, Jampol LM, et al. Persistent macular thickening following intravitreous Aflibercept, bevacizumab, or Ranibizumab for Central-Involved diabetic macular edema with vision impairment: A secondary analysis of a randomized clinical trial. JAMA Ophthalmol. 2018;136(3):257\u201369. https:\/\/doi.org\/10.1001\/jamaophthalmol.2017.6565","journal-title":"JAMA Ophthalmol"},{"issue":"19","key":"3993_CR4","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1001\/jama.2019.5790","volume":"321","author":"CW Baker","year":"2019","unstructured":"Baker CW, Glassman AR, Beaulieu WT, Antoszyk AN, Browning DJ, Chalam KV, et al. Effect of initial management with Aflibercept vs laser photocoagulation vs observation on vision loss among patients with diabetic macular edema involving the center of the macula and good visual acuity: A randomized clinical trial. JAMA. 2019;321(19):1880\u201394. https:\/\/doi.org\/10.1001\/jama.2019.5790","journal-title":"JAMA"},{"key":"3993_CR5","doi-asserted-by":"publisher","unstructured":"Madjedi K, Pereira A, Ballios BG, Arjmand P, Kertes PJ, Brent M et al. Switching between anti-VEGF agents in the management of refractory diabetic macular edema: A systematic review. Surv Ophthalmol 2022;67(5):1364\u201372. https:\/\/doi.org\/10.1016\/j.survophthal.2022.04.001","DOI":"10.1016\/j.survophthal.2022.04.001"},{"issue":"4","key":"3993_CR6","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.ajo.2011.08.041","volume":"153","author":"A Uji","year":"2012","unstructured":"Uji A, Murakami T, Nishijima K, Akagi T, Horii T, Arakawa N, et al. Association between hyperreflective foci in the outer retina, status of photoreceptor layer, and visual acuity in diabetic macular edema. Am J Ophthalmol. 2012;153(4):710. https:\/\/doi.org\/10.1016\/j.ajo.2011.08.041","journal-title":"Am J Ophthalmol"},{"key":"3993_CR7","doi-asserted-by":"publisher","first-page":"103167","DOI":"10.1016\/j.pdpdt.2022.103167","volume":"42","author":"F Horozoglu","year":"2023","unstructured":"Horozoglu F, Sener H, Polat OA, Temizyurek O, Evereklioglu C. Predictive impact of optical coherence tomography biomarkers in anti-vascular endothelial growth factor resistant macular edema treated with dexamethasone implant. Photodiagnosis Photodyn Ther. 2023;42:103167. https:\/\/doi.org\/10.1016\/j.pdpdt.2022.103167","journal-title":"Photodiagnosis Photodyn Ther"},{"issue":"1","key":"3993_CR8","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s40123-020-00324-z","volume":"10","author":"A Arrigo","year":"2021","unstructured":"Arrigo A, Aragona E, Capone L, Lattanzio R, Zollet P, Bandello F. Foveal Eversion: A possible biomarker of persistent diabetic macular edema. Ophthalmol Ther. 2021;10(1):115\u201326. https:\/\/doi.org\/10.1007\/s40123-020-00324-z","journal-title":"Ophthalmol Ther"},{"issue":"9","key":"3993_CR9","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1080\/02713683.2021.1878540","volume":"46","author":"ME Lu\u00eds","year":"2021","unstructured":"Lu\u00eds ME, Sampaio F, Costa J, Cabral D, Teixeira C, Ferreira JT. Dril influences Short-term visual outcome after intravitreal corticosteroid injection for refractory diabetic macular edema. Curr Eye Res. 2021;46(9):1378\u201386. https:\/\/doi.org\/10.1080\/02713683.2021.1878540","journal-title":"Curr Eye Res"},{"issue":"2","key":"3993_CR10","doi-asserted-by":"publisher","first-page":"e217","DOI":"10.1111\/aos.14230","volume":"98","author":"D Zur","year":"2020","unstructured":"Zur D, Iglicki M, Sala-Puigdollers A, Chhablani J, Lupidi M, Fraser-Bell S, et al. Disorganization of retinal inner layers as a biomarker in patients with diabetic macular oedema treated with dexamethasone implant. Acta Ophthalmol. 2020;98(2):e217\u201323. https:\/\/doi.org\/10.1111\/aos.14230","journal-title":"Acta Ophthalmol"},{"issue":"5","key":"3993_CR11","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s40265-017-0704-6","volume":"77","author":"SU Shah","year":"2017","unstructured":"Shah SU, Maturi RK. Therapeutic options in refractory diabetic macular oedema. Drugs. 2017;77(5):481\u201392. https:\/\/doi.org\/10.1007\/s40265-017-0704-6","journal-title":"Drugs"},{"issue":"3","key":"3993_CR12","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1097\/IAE.0000000000000770","volume":"36","author":"KH Seo","year":"2016","unstructured":"Seo KH, Yu SY, Kim M, Kwak HW, Visual and morphologic outcomes of intravitreal, ranibizumab for diabetic macular edema based on optical coherence tomography patterns. Retina. 2016;36(3):588\u201395. https:\/\/doi.org\/10.1097\/IAE.0000000000000770","journal-title":"Retina"},{"issue":"2","key":"3993_CR13","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1167\/iovs.16-20855","volume":"58","author":"A Giocanti-Aur\u00e9gan","year":"2017","unstructured":"Giocanti-Aur\u00e9gan A, Hrarat L, Qu LM, Sarda V, Boubaya M, Levy V, et al. Functional and anatomical outcomes in patients with serous retinal detachment in diabetic macular edema treated with Ranibizumab. Invest Ophthalmol Vis Sci. 2017;58(2):797\u2013800. https:\/\/doi.org\/10.1167\/iovs.16-20855","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"3993_CR14","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/j.ophtha.2015.02.036","volume":"122","author":"R Sophie","year":"2015","unstructured":"Sophie R, Lu N, Campochiaro PA. Predictors of functional and anatomic outcomes in patients with diabetic macular edema treated with Ranibizumab. Ophthalmology. 2015;122(7):1395\u2013401. https:\/\/doi.org\/10.1016\/j.ophtha.2015.02.036","journal-title":"Ophthalmology"},{"key":"3993_CR15","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.2147\/OPTH.S100764","volume":"10","author":"PU Dugel","year":"2016","unstructured":"Dugel PU, Hillenkamp J, Sivaprasad S, V\u00f6geler J, Mousseau MC, Wenzel A, et al. Baseline visual acuity strongly predicts visual acuity gain in patients with diabetic macular edema following anti-vascular endothelial growth factor treatment across trials. Clin Ophthalmol. 2016;10:1103\u201310. https:\/\/doi.org\/10.2147\/OPTH.S100764","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"3993_CR16","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1111\/febs.16330","volume":"290","author":"F O\u2019Leary","year":"2023","unstructured":"O\u2019Leary F, Campbell M. The blood-retina barrier in health and disease. FEBS J. 2023;290(4):878\u201391. https:\/\/doi.org\/10.1111\/febs.16330","journal-title":"FEBS J"},{"issue":"7","key":"3993_CR17","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.ophtha.2015.03.024","volume":"122","author":"A Das","year":"2015","unstructured":"Das A, McGuire PG, Rangasamy S. Diabetic macular edema: pathophysiology and novel therapeutic targets. Ophthalmology. 2015;122(7):1375\u201394. https:\/\/doi.org\/10.1016\/j.ophtha.2015.03.024","journal-title":"Ophthalmology"},{"key":"3993_CR18","doi-asserted-by":"publisher","unstructured":"Sorour OA, Levine ES, Baumal CR, Elnahry AG, Braun P, Girgis J et al. Persistent diabetic macular edema: definition, incidence, biomarkers, and treatment methods. Surv Ophthalmol 2023;68(2):147\u201374. https:\/\/doi.org\/10.1016\/j.survophthal.2022.11.008","DOI":"10.1016\/j.survophthal.2022.11.008"},{"issue":"5","key":"3993_CR19","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1167\/iovs.10-6518","volume":"52","author":"HZ Xu","year":"2011","unstructured":"Xu HZ, Le YZ. Significance of outer blood-retina barrier breakdown in diabetes and ischemia. Invest Ophthalmol Vis Sci. 2011;52(5):2160\u20134. https:\/\/doi.org\/10.1167\/iovs.10-6518","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"3993_CR20","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1016\/j.ophtha.2014.04.019","volume":"121","author":"J Cunha-Vaz","year":"2014","unstructured":"Cunha-Vaz J, Ashton P, Iezzi R, Campochiaro P, Dugel PU, Holz FG, et al. Sustained delivery Fluocinolone acetonide vitreous implants: long-term benefit in patients with chronic diabetic macular edema. Ophthalmology. 2014;121(10):1892\u2013903. https:\/\/doi.org\/10.1016\/j.ophtha.2014.04.019","journal-title":"Ophthalmology"},{"issue":"3","key":"3993_CR21","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1517\/14712598.2016.1131265","volume":"16","author":"RM Hussain","year":"2016","unstructured":"Hussain RM, Ciulla TA. Treatment strategies for refractory diabetic macular edema: switching anti-VEGF treatments, adopting corticosteroid-based treatments, and combination therapy. Expert Opin Biol Ther. 2016;16(3):365\u201374. https:\/\/doi.org\/10.1517\/14712598.2016.1131265","journal-title":"Expert Opin Biol Ther"},{"key":"3993_CR22","doi-asserted-by":"publisher","first-page":"1128811","DOI":"10.3389\/fmed.2023.1128811","volume":"10","author":"CD Haydinger","year":"2023","unstructured":"Haydinger CD, Ferreira LB, Williams KA, Smith JR. Mechanisms of macular edema. Front Med (Lausanne). 2023;10:1128811. https:\/\/doi.org\/10.3389\/fmed.2023.1128811","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"3993_CR23","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1097\/IAE.0b013e3182a48917","volume":"34","author":"S Sonoda","year":"2014","unstructured":"Sonoda S, Sakamoto T, Yamashita T, Shirasawa M, Otsuka H, Sonoda Y. Retinal morphologic changes and concentrations of cytokines in eyes with diabetic macular edema. Retina. 2014;34(4):741\u20138. https:\/\/doi.org\/10.1097\/IAE.0b013e3182a48917","journal-title":"Retina"},{"issue":"4","key":"3993_CR24","doi-asserted-by":"publisher","first-page":"e891","DOI":"10.1111\/aos.15008","volume":"100","author":"J Mao","year":"2022","unstructured":"Mao J, Zhang S, Zheng Z, Deng X, Liu C, Chen Y, et al. Prediction of anti-VEGF efficacy in diabetic macular oedema using intraocular cytokines and macular optical coherence tomography. Acta Ophthalmol. 2022;100(4):e891\u20138. https:\/\/doi.org\/10.1111\/aos.15008","journal-title":"Acta Ophthalmol"},{"issue":"4","key":"3993_CR25","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1182\/blood-2004-08-3178","volume":"105","author":"KH Hong","year":"2005","unstructured":"Hong KH, Ryu J, Han KH. Monocyte chemoattractant protein-1-induced angiogenesis is mediated by vascular endothelial growth factor-A. Blood. 2005;105(4):1405\u20137. https:\/\/doi.org\/10.1182\/blood-2004-08-3178","journal-title":"Blood"},{"issue":"1","key":"3993_CR26","doi-asserted-by":"publisher","first-page":"52","DOI":"10.4103\/0974-9233.92116","volume":"19","author":"S Rangasamy","year":"2012","unstructured":"Rangasamy S, McGuire PG, Das A. Diabetic retinopathy and inflammation: novel therapeutic targets. Middle East Afr J Ophthalmol. 2012;19(1):52\u20139. https:\/\/doi.org\/10.4103\/0974-9233.92116","journal-title":"Middle East Afr J Ophthalmol"},{"key":"3993_CR27","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.exer.2018.09.009","volume":"178","author":"ML Valle","year":"2019","unstructured":"Valle ML, Dworshak J, Sharma A, Ibrahim AS, Al-Shabrawey M, Sharma S. Inhibition of interleukin-6 trans-signaling prevents inflammation and endothelial barrier disruption in retinal endothelial cells. Exp Eye Res. 2019;178:27\u201336. https:\/\/doi.org\/10.1016\/j.exer.2018.09.009","journal-title":"Exp Eye Res"},{"key":"3993_CR28","doi-asserted-by":"publisher","unstructured":"Amer R, Nalc\u0131 H, Yal\u00e7\u0131nda\u011f N. Exudative retinal detachment. Surv Ophthalmol. 2017 Nov-Dec;62(6):723\u201369. https:\/\/doi.org\/10.1016\/j.survophthal.2017.05.001","DOI":"10.1016\/j.survophthal.2017.05.001"},{"issue":"4","key":"3993_CR29","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1159\/000519235","volume":"245","author":"S Touhami","year":"2022","unstructured":"Touhami S, Dupas B, Bertaud S, Tadayoni R, Couturier A. Intravitreal dexamethasone in diabetic macular oedema: A way of enhancing the response to Anti-VEGF in Non- or poor responders?? Ophthalmologica. 2022;245(4):350\u20137. https:\/\/doi.org\/10.1159\/000519235","journal-title":"Ophthalmologica"},{"key":"3993_CR30","doi-asserted-by":"publisher","unstructured":"Hatamnejad A, Orr S, Dadak R, Khanani A, Singh R, Choudhry N. Anti-VEGF and steroid combination therapy relative to anti-VEGF mono therapy for the treatment of refractory DME: A systematic review of efficacy and meta-analysis of safety. Acta Ophthalmol. 2023;26. https:\/\/doi.org\/10.1111\/aos.15724","DOI":"10.1111\/aos.15724"},{"issue":"10","key":"3993_CR31","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1007\/s00417-021-05148-6","volume":"259","author":"MS Halim","year":"2021","unstructured":"Halim MS, Afridi R, Hasanreisoglu M, Hassan M, Ibrahim-Ahmed M, Do DV, et al. Differences in the characteristics of subjects achieving complete, partial, or no resolution of macular edema in the READ-3 study. Graefes Arch Clin Exp Ophthalmol. 2021;259(10):2941\u20138. https:\/\/doi.org\/10.1007\/s00417-021-05148-6","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"5","key":"3993_CR32","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1167\/iovs.09-4493","volume":"52","author":"L Pelosini","year":"2011","unstructured":"Pelosini L, Hull CC, Boyce JF, McHugh D, Stanford MR, Marshall J. Optical coherence tomography May be used to predict visual acuity in patients with macular edema. Invest Ophthalmol Vis Sci. 2011;52(5):2741\u20138. https:\/\/doi.org\/10.1167\/iovs.09-4493","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"3993_CR33","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1001\/jamaophthalmol.2015.4599","volume":"134","author":"JA Wells","year":"2016","unstructured":"Wells JA, Glassman AR, Jampol LM, Aiello LP, Antoszyk AN, Baker CW, et al. Association of baseline visual acuity and retinal thickness with 1-Year efficacy of Aflibercept, bevacizumab, and Ranibizumab for diabetic macular edema. JAMA Ophthalmol. 2016;134(2):127\u201334. https:\/\/doi.org\/10.1001\/jamaophthalmol.2015.4599","journal-title":"JAMA Ophthalmol"},{"issue":"4","key":"3993_CR34","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1002\/glia.23727","volume":"68","author":"A Reichenbach","year":"2020","unstructured":"Reichenbach A, Bringmann A. Glia of the human retina. Glia. 2020;68(4):768\u201396. https:\/\/doi.org\/10.1002\/glia.23727","journal-title":"Glia"},{"key":"3993_CR35","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.preteyeres.2018.03.006","volume":"66","author":"A Bringmann","year":"2018","unstructured":"Bringmann A, Syrbe S, G\u00f6rner K, Kacza J, Francke M, Wiedemann P, et al. The primate fovea: structure, function and development. Prog Retin Eye Res. 2018;66:49\u201384. https:\/\/doi.org\/10.1016\/j.preteyeres.2018.03.006","journal-title":"Prog Retin Eye Res"},{"key":"3993_CR36","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.exer.2017.12.004","volume":"167","author":"S Syrbe","year":"2018","unstructured":"Syrbe S, Kuhrt H, G\u00e4rtner U, Habermann G, Wiedemann P, Bringmann A, et al. M\u00fcller glial cells of the primate foveola: an electron microscopical study. Exp Eye Res. 2018;167:110\u20137. https:\/\/doi.org\/10.1016\/j.exer.2017.12.004","journal-title":"Exp Eye Res"},{"issue":"4","key":"3993_CR37","doi-asserted-by":"publisher","first-page":"e447","DOI":"10.1111\/aos.14289","volume":"98","author":"A Bringmann","year":"2020","unstructured":"Bringmann A, Duncker T, Jochmann C, Barth T, Duncker GIW, Wiedemann P. Spontaneous closure of small full-thickness macular holes: presumed role of M\u00fcller cells. Acta Ophthalmol. 2020;98(4):e447\u201356. https:\/\/doi.org\/10.1111\/aos.14289","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"3993_CR38","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1177\/11206721211026106","volume":"32","author":"S Saxena","year":"2022","unstructured":"Saxena S, Meyer CH, Akduman L. External limiting membrane and ellipsoid zone structural integrity in diabetic macular edema. Eur J Ophthalmol. 2022;32(1):15\u20136. https:\/\/doi.org\/10.1177\/11206721211026106","journal-title":"Eur J Ophthalmol"},{"issue":"1","key":"3993_CR39","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1600-0420.2005.00387.x","volume":"83","author":"H Ozdemir","year":"2005","unstructured":"Ozdemir H, Karacorlu M, Karacorlu S. Serous macular detachment in diabetic cystoid macular oedema. Acta Ophthalmol Scand. 2005;83(1):63\u20136. https:\/\/doi.org\/10.1111\/j.1600-0420.2005.00387.x","journal-title":"Acta Ophthalmol Scand"},{"issue":"5","key":"3993_CR40","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1080\/08820538.2022.2069470","volume":"37","author":"I Chatziralli","year":"2022","unstructured":"Chatziralli I, Dimitriou E, Lambadiari V, Kazantzis D, Kapsis P, Theodossiadis G, et al. The impact of laboratory findings and optical coherence tomography biomarkers on response to intravitreal Anti-VEGF treatment in patients with diabetic macular edema. Semin Ophthalmol. 2022;37(5):668\u201375. https:\/\/doi.org\/10.1080\/08820538.2022.2069470","journal-title":"Semin Ophthalmol"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-03993-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-025-03993-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-03993-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T02:05:31Z","timestamp":1744164331000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-025-03993-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3993"],"URL":"https:\/\/doi.org\/10.1186\/s12886-025-03993-1","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,7]]},"assertion":[{"value":"21 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective observational study was approved by the Ethics Committee of Beijing Friendship Hospital, Capital Medical University [approval number: 2022-P2-227-01]. All the procedures adhered to the principles outlined in the Declaration of Helsinki. All participants signed the informed consent form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"177"}}